ArticleAnnals of the rheumatic diseases2019

Fexofenadine inhibits TNF signaling through targeting to cytosolic phospholipase A2 and is therapeutic against inflammatory arthritis.

Ronghan Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.